Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$57.72 - $65.01 $144 Million - $163 Million
-2,500,000 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$57.92 - $72.58 $14.5 Million - $18.1 Million
250,000 Added 11.11%
2,500,000 $149 Million
Q4 2021

Feb 14, 2022

BUY
$64.88 - $73.64 $74.6 Million - $84.7 Million
1,150,000 Added 104.55%
2,250,000 $163 Million
Q3 2021

Nov 15, 2021

SELL
$67.69 - $73.03 $20.3 Million - $21.9 Million
-300,000 Reduced 21.43%
1,100,000 $76.8 Million
Q2 2021

Aug 16, 2021

BUY
$63.47 - $69.35 $25.4 Million - $27.7 Million
400,000 Added 40.0%
1,400,000 $96.4 Million
Q1 2021

May 17, 2021

BUY
$60.0 - $68.46 $60 Million - $68.5 Million
1,000,000 New
1,000,000 $64.6 Million
Q1 2020

May 15, 2020

SELL
$62.63 - $80.22 $93.9 Million - $120 Million
-1,500,000 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$61.62 - $67.78 $92.4 Million - $102 Million
1,500,000 New
1,500,000 $97.5 Million
Q3 2019

Nov 14, 2019

SELL
$62.51 - $69.0 $62.5 Million - $69 Million
-1,000,000 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$61.87 - $69.38 $61.9 Million - $69.4 Million
1,000,000 New
1,000,000 $67.6 Million
Q4 2017

Feb 14, 2018

SELL
$71.15 - $83.52 $35.6 Million - $41.8 Million
-500,000 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$72.11 - $85.47 $36.1 Million - $42.7 Million
500,000
500,000 $40.5 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Camber Capital Management LP Portfolio

Follow Camber Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Camber Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Camber Capital Management LP with notifications on news.